School of Medicine
Showing 101-110 of 1,250 Results
-
Nidhi Bhutani
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsThe long-term goal of our research is to understand the fundamental mechanisms that govern and reprogram cellular fate during development, regeneration and disease.
-
Vinod (Vinny) K. Bhutani
Professor of Pediatrics (Neonatology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsNeonatology; newborn jaundice, bilirubin biology and kernicterus prevention; pulmonary physiology, pulmonary functions and neonatal ventilation. To promote newborn screening for G6PD deficiency in USA.
-
Y. Katherine Bianco
Clinical Professor, Obstetrics & Gynecology - Maternal Fetal Medicine
BioI am Latinx Maternal-Fetal Medicine specialist and Medical Geneticist and a Professor of Obstetrics and Gynecology at Stanford University. I direct the Maternal Heart Program at Stanford Children’s Hospital and Clinics, leading a multidisciplinary team caring for complex cardiac conditions in pregnancy. I am dedicated educator and mentor, that have trained more than 50 trainees spanning from high school students to junior faculty. I serve in the Dean’s Office for Faculty Professional Development and Engagement and oversees the OBGYN Advance and Promotions, where i support advances programs to support faculty growth, mentorship, and academic success. My work integrates genetics, cardiology, and maternal health to improve outcomes for women and families. My clinical interest in pregnancies complicated with birth defects has led my underlying research interests in genomic abnormalities in the human trophoblast carrying to faulty placentation. The latter began with initial work during K12 and KO8 funding. I took a great interest in the human placenta as it carries potential advantages over other tissues sources: first, this highly metabolically active organ is the potential source of many transcripts. Second, the placenta forms at a very early stage of embryonic development, potentially allowing detection of primary alterations as compared to secondary changes that may mask the underlying causal phenomena. Finally, studying early placentation may provide targets for development of novel molecular approaches, such as up-regulate or down-regulate genes, the protein products of which could potentially serve as molecular surrogates for diagnosis and treatment of pregnancy complication such as miscarriages, pre-eclampsia, pregnancy induced hypertension and intrauterine growth retardation. This work has led to the first Trisomy 21, Trisomy 18, trisomy 13 cell lines established from human placentas making it possible to apply gene editing in the early stages of human trophoblast development.
As my primary clinical responsibility involves treating patients needing medical care and support through their high risk pregnancies, I am interested in factors that may impact outcomes, such as prenatal screening and diagnosis, maternal heart conditions, labor and delivery management, and safety approaches for the second stage of labor.
With regards to my interest in fetal medicine, I have worked in collaboration with other specialists such as radiologists and pediatric cardiologists utilizing imagining studies to assess and determine successful perinatal care and fetal survival.
. My career has been defined by a commitment to addressing the most pressing drivers of maternal morbidity and mortality, particularly cardiovascular disease in pregnancy. I have led multidisciplinary maternal cardiac programs at UCSF and Stanford, impacting over 600 high-risk pregnancies and demonstrating how team-based care transforms outcomes.
Beyond clinical innovation, my work spans translational science and global health. I have contributed to advancing prenatal diagnostics—validating tools for non-invasive prenatal testing, improving detection of conditions like Down syndrome. Globally, I’ve led training initiatives in countries with high maternal mortality, such as India, Guatemala, El Salvador, and Costa Rica, building capacity through education and simulation.
Equally central is mentorship. I have mentored over 50 trainees across all levels, fostering diversity and advancing women in medicine. My work goes beyond language access to cultural humility, improving care for diverse populations.
As a physician who bridges worlds—from my modest beginnings in a lower-middle-income country, through medical training in the U.S., to leading at Stanford—I know that diverse paths shape stronger futures. I believe that every mother’s life saved is a generation empowered—and through science, mentorship, and equity, -
Mahamaya Biswal
Postdoctoral Scholar, Molecular and Cellular Physiology
BioMahamaya is a postdoctoral researcher in the Department of Molecular and Cellular Physiology at Stanford University, where she specializes in Cellular and structural biology with a focus on membrane protein biogenesis, quality control, and the development of innovative nanobody technologies. Her research integrates advanced cryo-electron microscopy (cryo-EM), cell biology, and nanobody engineering to unravel the mechanisms governing the assembly and maturation of membrane protein biogenesis factor hubs with a focus on Voltage gated ion channels as a model substrate.
Dr. Biswal’s scientific journey began with an integrated M.Tech in Biotechnology degree from D.Y. Patil University, India, where she conducted foundational research on bacterial persister cell formation at BARC and characterized breast cancer proteins ZBRK1 and BRCA1 at ACTREC,. After spending a brief time in biotech industry at Yashraj Biotechnology Ltd., Mumbai, optimizing purification pipelines for cancer antigens used in diagnostic kits and facilitating technology transfer from R&D to manufacturing, she moved to US to join UC Riverside’s PhD program under Department of Biochemistry and supervision of Dr. Jikui Song. She made significant advances in understanding the structural dynamics of SARS-CoV-2 proteins. Notably, she solved the X-ray crystal structure of the NSP7-8 complex, a key cofactor for the viral replicase, and also elucidated the interaction between the viral nucleocapsid protein and human G3BP1. Her doctoral and postdoctoral work has also contributed to studies on viral immune evasion, including the structural basis for STAT2 antagonization by DENV2 NS5.
At Stanford, Dr. Biswal has expanded her expertise to the structural and functional study of G protein-coupled receptors (GPCRs) and currently focusing on gaining mechanistic insights on Membrane protein biogenesis factor hubs by combining cell biology and structural biology expertise. She is also developing nanobody libraries targeting synaptic vesicles and bacterial death effectors for in situ tomography and potential therapeutic applications respectively. Dr. Biswal is a committed mentor, having supervised graduate and undergraduate students, and is dedicated to fostering diversity and inclusion in science through active involvement in organizations such as AWIS, BioAIMS, and BSS (India). Her scientific contributions have been recognized with honors including the HEERF Dissertation Year Fellowship, the Mary K. and Randolph T. Wedding Prize, and best poster awards at UC Riverside. Dr. Biswal’s long-term vision is to lead a research program that translates structural insights into therapeutic strategies for neurological and infectious diseases, advancing both scientific knowledge and the next generation of scientists. -
Rebecca Blankenburg, MD, MPH
Clinical Professor, Pediatrics
Current Research and Scholarly InterestsMy educational research interests focus on building a more diverse, inclusive and equitable learning environment and helping develop a sense of belonging, professional identity formation, and competence through longitudinal coaching and scholarly mentorship.
-
Helen M. Blau
Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsProf. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.
